Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease

This publication has 19 references indexed in Scilit:

• Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography
  Brain Research, 1994
• Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons
  Annals of Neurology, 1994
• A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter
  Cell, 1992
• Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D_25k—Containing Cells^a
  Annals of the New York Academy of Sciences, 1992
• Mitochondrial function in Parkinson's disease
  Annals of Neurology, 1992
• Dopamine uptake: A review of progress in the last decade
  Progress in Neurobiology, 1990
• MPTP-induced parkinsonism in monkeys: Mechanism of action, selectivity and pathophysiology
  General Pharmacology: The Vascular System, 1988
• Rate of cell death in parkinsonism indicates active neuropathological process
  Annals of Neurology, 1988
• Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
  Nature, 1988
• Time course of nigrostriatal degeneration in parkinson's disease
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1976